image
Healthcare - Biotechnology - NASDAQ - US
$ 1.15
6.48 %
$ 2.45 M
Market Cap
-0.32
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
141.42%
Net Income Estimate
--180.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Salarius Pharmaceuticals, Inc.
image
SLRX has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart SLRX

image
$12.0m$12.0m$10.0m$10.0m$8.0m$8.0m$6.0m$6.0m$4.0m$4.0m$2.0m$2.0m$0.0$0.020162016201720172018201820192019202020202021202120232023202420242025202520262026
EBIT FORECAST

EBIT Forecast Chart SLRX

image
$5.0m$5.0m$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)($40.0m)($40.0m)20162016201720172018201820192019202020202021202120232023202420242025202520262026
NET INCOME FORECAST

Net Income Chart SLRX

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)20162016201720172018201820192019202020202021202120232023202420242025202520262026